Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Haller

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
Frontiers in Nutrition|November 16, 2020
A Phenotyping Platform to Characterize Healthy Individuals Across Four Stages of Life - The <i>Enable</i> StudyBeate Brandl, Thomas Skurk, Rachel Rennekamp, et al.
Gut Microbes|February 18, 2011
Safety assessment of probiotics for human useMary Ellen Sanders, Louis M A Akkermans, Dirk Haller, et al.
Gut|April 4, 2023
<i>Helicobacter pylori</i> promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signatureAnna Ralser, Alisa Dietl, Sebastian Jarosch, et al.
Scientific Reports|September 10, 2017
Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat dietsAlesia Walker, Barbara Pfitzner, Mourad Harir, et al.
Gastroenterology|August 1, 2018
Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal TumorigenesisOlivia I Coleman, Elena M Lobner, Sandra Bierwirth, et al.
Nature Reviews. Gastroenterology & Hepatology|March 3, 2025
A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome researchAmira Metwaly, Aicha Kriaa, Zahra Hassani, et al.
Nature Biotechnology|April 29, 2025
Enabling next-generation anaerobic cultivation through biotechnology to advance functional microbiome researchThomas Clavel, Franziska Faber, Mathieu Groussin, et al.
Nature Communications|July 18, 2025
Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseasesFeng Xian, Malena Brenek, Christoph Krisp, et al.
Molecular Metabolism|December 1, 2016
Dietary fat and gut microbiota interactions determine diet-induced obesity in miceRaphaela Kübeck, Catalina Bonet-Ripoll, Christina Hoffmann, et al.
Journal of Fungi (Basel, Switzerland)|December 22, 2022
Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary AspergillosisH Carlo Maurer, David Schult, Plamena Koyumdzhieva, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
Frontiers in Nutrition|November 16, 2020
A Phenotyping Platform to Characterize Healthy Individuals Across Four Stages of Life - The <i>Enable</i> StudyBeate Brandl, Thomas Skurk, Rachel Rennekamp, et al.
Gut Microbes|February 18, 2011
Safety assessment of probiotics for human useMary Ellen Sanders, Louis M A Akkermans, Dirk Haller, et al.
Gut|April 4, 2023
<i>Helicobacter pylori</i> promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signatureAnna Ralser, Alisa Dietl, Sebastian Jarosch, et al.
Scientific Reports|September 10, 2017
Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat dietsAlesia Walker, Barbara Pfitzner, Mourad Harir, et al.
Gastroenterology|August 1, 2018
Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal TumorigenesisOlivia I Coleman, Elena M Lobner, Sandra Bierwirth, et al.
Nature Reviews. Gastroenterology & Hepatology|March 3, 2025
A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome researchAmira Metwaly, Aicha Kriaa, Zahra Hassani, et al.
Nature Biotechnology|April 29, 2025
Enabling next-generation anaerobic cultivation through biotechnology to advance functional microbiome researchThomas Clavel, Franziska Faber, Mathieu Groussin, et al.
Nature Communications|July 18, 2025
Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseasesFeng Xian, Malena Brenek, Christoph Krisp, et al.
Molecular Metabolism|December 1, 2016
Dietary fat and gut microbiota interactions determine diet-induced obesity in miceRaphaela Kübeck, Catalina Bonet-Ripoll, Christina Hoffmann, et al.
Journal of Fungi (Basel, Switzerland)|December 22, 2022
Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary AspergillosisH Carlo Maurer, David Schult, Plamena Koyumdzhieva, et al.
Pageof 24